Type 2 diabetes and anxiety symptoms: a cross-sectional study in Peru
Descripción del Articulo
Objective: To determine the association between diabetes mellitus type 2 and anxiety symptoms using a population-based study from the semi urban population of Tumbes, Peru. Research design and methods: The present study was an observational, analytical cross-sectional one. Data from a population-bas...
Autores: | , |
---|---|
Formato: | tesis de grado |
Fecha de Publicación: | 2021 |
Institución: | Universidad Peruana de Ciencias Aplicadas |
Repositorio: | UPC-Institucional |
Lenguaje: | español |
OAI Identifier: | oai:repositorioacademico.upc.edu.pe:10757/656152 |
Enlace del recurso: | http://hdl.handle.net/10757/656152 |
Nivel de acceso: | acceso abierto |
Materia: | Anxiety symptoms Diabetes mellitus type Population groups Awareness Síntomas de ansiedad Diabetes mellitus tipo 2 Estudio poblacional http://purl.org/pe-repo/ocde/ford#3.00.00 https://purl.org/pe-repo/ocde/ford#3.01.00 |
Sumario: | Objective: To determine the association between diabetes mellitus type 2 and anxiety symptoms using a population-based study from the semi urban population of Tumbes, Peru. Research design and methods: The present study was an observational, analytical cross-sectional one. Data from a population-based study conducted in Tumbes, Peru between 2016 and 2017 was analyzed. The variables studied were T2DM, defined using fasting glucose and anxiety symptoms, using the Goldberg scale. Results: Data from 1609 individuals was analyzed, with mean age 48.16 (SD:10.61) and 810 women (50.3%), where a total of 161 were classified as having T2DM (10.0%; CI 95%: 8.5%-11.4%) and 675 individuals had anxiety symptoms (41.95%; CI 95%:39.5%-44.3%). A statistically significant association was found between DM2 and anxiety symptoms (p <0.001). Furthermore, those patients aware of their diagnosis of diabetes over 5 years had a 56% (95% CI: 25% - 96%) higher prevalence of anxiety symptoms compared to participants without DM2. Conclusion: An association was found between DM2 and anxiety symptoms; there being a higher prevalence of anxiety symptoms in participants previously aware of having DM2. Periodic monitoring of anxiety symptoms is recommended in these patients. |
---|
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).